Radius Health Inc - ESG Rating & Company Profile powered by AI
Browse to the end of the webpage for potential risks for Radius Health Inc based on industry, geography and size. This assessment of Radius Health Inc leverages information from across the web and also from available filings by Radius Health Inc. This SDG assessment for Radius Health Inc indicates the company's reporting of the UN Sustainable Development Goals.
Radius Health Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
314 | Trulieve Cannabis Corp | 6.8 | High |
314 | Vicore Pharma Holding AB | 6.8 | High |
337 | Radius Health Inc | 6.7 | High |
337 | Calyxt Inc | 6.7 | High |
337 | CanSino Biologics Inc | 6.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Radius Health Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Radius Health Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Radius Health Inc report the average age of the workforce?
Sign up for free to unlockDoes Radius Health Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Radius Health Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Radius Health Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Radius Health Inc offer flexible work?
Sign up for free to unlockDoes Radius Health Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Radius Health Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Radius Health Inc conduct supply chain audits?
Sign up for free to unlockDoes Radius Health Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Radius Health Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Radius Health Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Radius Health Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Radius Health Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Radius Health Inc disclose water use targets?
Sign up for free to unlockDoes Radius Health Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Radius Health Inc have a product recall in the last two years?
Sign up for free to unlockDoes Radius Health Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Radius Health Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Radius Health Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Radius Health Inc disclose parental leave metrics?
Sign up for free to unlockDoes Radius Health Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Radius Health Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Radius Health Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Radius Health Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Radius Health Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Radius Health Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Radius Health Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Radius Health Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Radius Health Inc disclose its waste policy?
Sign up for free to unlockDoes Radius Health Inc report according to TCFD requirements?
Sign up for free to unlockDoes Radius Health Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Radius Health Inc disclose energy use targets?
Sign up for free to unlockDoes Radius Health Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Radius Health Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Radius Health Inc
These potential risks are based on the size, segment and geographies of the company.
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.